1-5 of 5
Naosuke Arima
Close
Sort by
Journal Articles

Clinical Course of Adult T-Cell Leukemia-Lymphoma with Central Nervous System Involvement

Takuya Ueno, Makoto Yoshimitsu, Momone Sameshima, Taichi Nagano, Rika Akahoshi, Yusetsu Takeshita, Aya Shodai, Kodai Shima, Naosuke Arima, Maiko Hayashida, Daisuke Nakamura, Kenji Ishitsuka
Journal: Blood
Blood (2023) 142 (Supplement 1): 3119.
https://doi.org/10.1182/blood-2023-188851
Published: 2023
Journal Articles

Validation of the Usefulness of Satl-PI and JCOG-PI As Predictors of Prognosis at the Start of Second-Line Treatment

Daisuke Nakamura, Tomohisa Tabuchi, Naosuke Arima, Maiko Hayashida, Akihiko Arai, Makoto Yoshimitsu, Kenji Ishitsuka
Journal: Blood
Blood (2022) 140 (Supplement 1): 3792–3793.
https://doi.org/10.1182/blood-2022-159818
Published: 2022
Journal Articles

A Novel Recurrent Gain-of-Function Mutation of Rltpr Q575E in Adult T Cell Leukemia/Lymphoma

Yuichiro Uchida, Makoto Yoshimitsu, MD PhD, Yuhei Kamada, MD PhD, Naosuke Arima, MD, Kenji Ishitsuka, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1489.
https://doi.org/10.1182/blood-2019-124641
Published: 2019
Journal Articles

Prediction for the Risk of Gvhd after Allogeneic HSCT in Patients with ATL Treated By Mogamulizumab

Yuhei Kamada, MD PhD, Ayako Kuroki, PhD, Naosuke Arima, MD, Maiko Hayashida, MD, Daisuke Nakamura, MD PhD, Makoto Yoshimitsu, MD PhD, Kenji Ishitsuka, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3290.
https://doi.org/10.1182/blood-2019-126912
Published: 2019
Journal Articles

OPEC/Mpec for Adult T-Cell Leukemia/Lymphoma: A Single-Institution Study

Daisuke Nakamura, MD, PhD, Makoto Yoshimitsu, MD, PhD, Tomohisa Tabuchi, MD, Naosuke Arima, MD, Maiko Hayashida, MD, Hirosaka Inoue, MD, Kakushi Matsushita, MD, PhD, Tadashi Matsumoto, MD, PhD, Naomichi Arima, MD, PhD, Kenji Ishitsuka, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 1828.
https://doi.org/10.1182/blood.V128.22.1828.1828
Published: 2016